Advertisement
Canada markets open in 1 hour 40 minutes

  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CAD/USD

    0.7305
    -0.0016 (-0.21%)
     

  • CRUDE OIL

    82.83
    -0.53 (-0.64%)
     

  • Bitcoin CAD

    90,996.56
    +692.11 (+0.77%)
     

  • CMC Crypto 200

    1,438.51
    +14.41 (+1.01%)
     

  • GOLD FUTURES

    2,328.60
    -13.50 (-0.58%)
     

  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • NASDAQ futures

    17,721.25
    +114.50 (+0.65%)
     

  • VOLATILITY

    15.77
    +0.08 (+0.51%)
     

  • FTSE

    8,089.24
    +44.43 (+0.55%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6835
    -0.0001 (-0.01%)
     

Marinus Pharmaceuticals (MRNS) Catches Eye: Stock Jumps 7.7%

Zacks Equity Research

Marinus Pharmaceuticals, Inc. MRNS was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 136.8% in the past one-month time frame.

The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Marinus Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Marinus Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Marinus Pharmaceuticals, Inc. Price

Marinus Pharmaceuticals, Inc. Price
Marinus Pharmaceuticals, Inc. Price

Marinus Pharmaceuticals, Inc. price | Marinus Pharmaceuticals, Inc. Quote

ADVERTISEMENT

A better-ranked stock in the Medical – Drugs industry is Ironwood Pharmaceuticals, Inc. IRWD, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is MRNS going up? Or down? Predict to see what others think: Up or Down

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Ironwood Pharmaceuticals, Inc. (IRWD) : Free Stock Analysis Report
 
Marinus Pharmaceuticals, Inc. (MRNS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research